Evidence map›Paper›PMID 25752990›Full record

ArticlePacing and clinical electrophysiology : PACE2015

VV' Alternans Triplets on Near-Field ICD Intracardiac Electrogram is Associated with Mortality.

Mathias Baumert, Muammar M Kabir, Khidir Dalouk, Charles A Henrikson, Larisa G Tereshchenko

Registry-linked trialAbstract read
In one paragraph

Article in Pacing and clinical electrophysiology : PACE, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00916435 (Prospective Observational Study of the ICD Intracardiac Electrograms for Prediction of Ventricular Tachyarrhythmias and Congestive Heart Failure), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00916435 completednot on this map

Prospective Observational Study of the ICD Intracardiac Electrograms for Prediction of Ventricular Tachyarrhythmias and Congestive Heart Failure

TypeobservationalSponsorJohns Hopkins UniversityRan2005 to 2011Enrolled630ConditionsCongestive Heart Failure, Sudden Cardiac Death, Arrhythmia, Cardiomyopathies
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mathias BaumertSchool of Electrical and Electronic Engineering, The University of Adelaide, Adelaide, Australia.
Muammar M Kabir
Khidir Dalouk
Charles A Henrikson
Larisa G Tereshchenko
Oregon Health & Science University · USUniversity of Adelaide · AUJohns Hopkins Medicine · US

Funding

Novel ECG Measures and Risk of Sudden Cardiac DeathR01HL118277 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TERESHCHENKO, LARISA GENNADIEVNA · 2013 to 2016
$1.5M
NHLBI NIH HHS R01 HL118277NHLBI NIH HHS R01HL118277
6 · The paper itself

Abstract

backgroundIn heart failure patients with implantable cardioverter defibrillator (ICD) the risk of death from causes other than tachyarrhythmia is substantial. Benefit from ICD is determined by two competing risks: appropriate ICD shock or nonarrhythmic death. The goal of the study was to test predictors of competing outcomes.

methodsPatients with structural heart disease (N = 234, mean age 58.5 ± 15.1; 71% men, 80% whites, 61% ischemic cardiomyopathy) and primary (75%) or secondary prevention ICD underwent a 5-minute baseline near-field electrogram (NF EGM) recording. VV' alternans triplets were quantified as a percentage of three sinus VV' cycles sequences of "short-long-short" or "long-short-long" order. Appropriate ICD shock for fast ventricular tachycardia (FVT, cycle length ≤240 ms)/ventricular fibrillation (VF) and composite nonarrhythmic death (pump failure death or heart transplant) served as competing outcomes.

resultsOver a median follow-up of 2.4 years, 26 patients (4.6% per person-year of follow-up) developed FVT/VF with ICD shock, and 35 (6.3% per person-year of follow-up) had nonarrhythmic death. In competing risk analysis, after adjustment for demographics, left ventricular ejection fraction, New York Heart Association class, cardiomyopathy type, use of class I antiarrhythmics, and diabetes, increased percentage of VV' alternans triplets (>69%) was associated with nonarrhythmic death (subhazard ratio [SHR] 2.09; 95% confidence interval [CI] 1.03-4.23; P = 0.041), rather than with FVT/VF (SHR 1.05; 95% CI 0.45-2.46; P = 0.901). Risk of nonarrhythmic death was especially high in diabetics with VV' alternans triplets in the highest quartile (SHR 3.46; 95% CI 1.41-8.50; P = 0.007).

conclusionIn ICD patients with structural heart disease sinus VV' alternans triplets on NF EGM is independently associated with nonarrhythmic death, rather than with FVT/VF.

Indexed as

Electrophysiologic Techniques, CardiacArrhythmias, CardiacDefibrillators, ImplantableFemaleHeart FailureHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk Factorscompeting riskimplantable cardioverter defibrillatormortalityventricular arrhythmia

Identifiers

PMID25752990
PMCPMC4414906
OpenAlexW1765647975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.